Cargando…

Audit feedback interventions to address high-risk prescriptions in long-term care homes: a costing study and return on investment analysis

BACKGROUND: Audit and feedback is a common implementation strategy, but few studies describe its costs. ‘MyPractice’ is a province-wide audit and feedback initiative to improve prescribing in nursing homes. This study sought to estimate the costs of ‘MyPractice’ and assess whether the financial bene...

Descripción completa

Detalles Bibliográficos
Autores principales: Thavorn, Kednapa, Kumar, Srishti, Reis, Catherine, Lam, Jonathan, Dobell, Gail, Mulhall, Cara, Grimshaw, Jeremy M., Ivers, Noah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554856/
https://www.ncbi.nlm.nih.gov/pubmed/34711294
http://dx.doi.org/10.1186/s43058-021-00225-7
Descripción
Sumario:BACKGROUND: Audit and feedback is a common implementation strategy, but few studies describe its costs. ‘MyPractice’ is a province-wide audit and feedback initiative to improve prescribing in nursing homes. This study sought to estimate the costs of ‘MyPractice’ and assess whether the financial benefit of ‘MyPractice’ offsets those costs. METHODS: We conducted a costing study from the perspective of the Ontario government. Total cost of ‘MyPractice’ was calculated as the sum of the costs of producing and disseminating the reports (covering three report releases) which were obtained from Ontario Health staff interviews and document reviews. Return on investment (ROI) was calculated as the ratio of net cost-savings and the intervention cost. Cost savings were based on the effectiveness of ‘MyPractice’ derived from a published cohort study. Cost-savings attributable to ‘MyPractice’ were estimated from the changes in the rates of antipsychotics over time between physicians who signed up and viewed the reports and those who did not sign up to the reports. RESULTS: Total intervention costs were C$223,691 (C$838 per physician and C$74,564 per release). Costs incurred during the development phase accounted for 74% of the total cost (C$166,117), while implementation costs for three report releases were responsible for 26% of the total costs (C$57,575). The ROI for every C$1 spent on the ‘MyPractice’ intervention was 1.02 (95% CI 0.51, 1.93) for three report releases. CONCLUSION: ‘MyPractice’ report offers a good return on investment and the value for money could improve with greater number of report releases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43058-021-00225-7.